{
    "root": "363540ff-7b66-daa5-e063-6394a90a3396",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "DOXYCYCLINE",
    "value": "20250528",
    "ingredients": [
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357"
        },
        {
            "name": "GELATIN",
            "code": "2G86QN327L"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "POTASSIUM HYDROXIDE",
            "code": "WZH3C48M4T"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A CORN",
            "code": "AG9B65PV6B"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "DOXYCYCLINE",
            "code": "N12000U13O"
        }
    ],
    "indications": "reduce development drug-resistant bacteria maintain effectiveness doxycycline capsules antibacterial drugs , doxycycline capsules used treat prevent infections proven strongly suspected caused susceptible bacteria . culture susceptibility information available , considered selecting modifying antibacterial therapy . absence data , local epidemiology susceptibility patterns may contribute empiric selection therapy . doxycycline indicated treatment following infections : rocky mountain spotted fever , typhus fever typhus group , q fever , rickettsialpox , tick fevers caused rickettsiae . respiratory tract infections caused mycoplasma pneumoniae . lymphogranuloma venereum caused chlamydia trachomatis . psittacosis ( ornithosis ) caused chlamydophila psittaci . trachoma caused chlamydia trachomatis , although infectious agent always eliminated judged immunofluorescence . inclusion conjunctivitis caused chlamydia trachomatis . uncomplicated urethral , endocervical rectal infections adults caused chlamydia trachomatis . nongonococcal urethritis caused ureaplasma urealyticum . relapsing fever due borrelia recurrentis . doxycycline also indicated treatment infections caused following gram-negative microorganisms : chancroid caused haemophilus ducreyi . plague due yersinia pestis . tularemia due francisella tularensis . cholera caused vibrio cholerae . campylobacter fetus infections caused campylobacter fetus . brucellosis due brucella species ( conjunction streptomycin ) . bartonellosis due bartonella bacilliformis . granuloma inguinale caused klebsiella granulomatis . many strains following groups microorganisms shown resistant doxycycline , culture susceptibility testing recommended . doxycycline indicated treatment infections caused following gram-negative microorganisms , bacteriologic testing indicates appropriate susceptibility : escherichia coli enterobacter aerogenes shigella species acinetobacter species respiratory tract infections caused haemophilus influenzae . respiratory tract urinary tract infections caused klebsiella species . doxycycline indicated treatment infections caused following gram-positive microorganisms bacteriologic testing indicates appropriate susceptibility : upper respiratory infections caused streptococcus pneumoniae . anthrax due bacillus anthracis , including inhalational anthrax ( post-exposure ) : reduce incidence progression disease following exposure aerosolized bacillus anthracis . penicillin contraindicated , doxycycline alternative treatment following infections : uncomplicated gonorrhea caused neisseria gonorrhoeae . syphilis caused treponema pallidum . yaws caused treponema pallidumsubspecies pertenue . listeriosis due listeria monocytogenes . vincent 's infection caused fusobacterium fusiforme . actinomycosis caused actinomyces israelii . infections caused clostridium species . acute intestinal amebiasis , doxycycline may useful adjunct amebicides . severe acne , doxycycline may useful adjunctive therapy .",
    "contraindications": "usual frequency doxycycline differs tetracyclines . exceeding recommended may result increased incidence side effects .",
    "warningsAndPrecautions": "doxycycline capsules usp , 100 mg brown opaque cap yellow opaque body imprinted `` lu `` cap white ink `` m73 `` body black ink filled light yellow grey colored blend . capsule contains doxycycline monohydrate usp equivalent 100 mg doxycycline . doxycycline capsules usp , 100 mg available : ndc : 70518-0213-00 ndc : 70518-0213-01 ndc : 70518-0213-02 ndc : 70518-0213-03 ndc : 70518-0213-04 ndc : 70518-0213-05 ndc : 70518-0213-06 ndc : 70518-0213-07 ndc : 70518-0213-08 ndc : 70518-0213-09 packaging : 30 1 blister pack packaging : 20 1 blister pack packaging : 14 1 bottle plastic packaging : 20 1 bottle plastic packaging : 42 1 bottle plastic packaging : 2 1 bottle plastic packaging : 100 1 bottle plastic packaging : 14 1 blister pack packaging : 60 1 bottle plastic packaging : 30 1 bottle plastic store 25°c ( 77°f ) ; excursions permitted 15 30°c ( 59 86°f ) [ usp controlled room temperature ] . protect light . dispense tight , light-resistant container defined usp/nf . dispense tight container [ usp ] . repackaged distributed : remedy repack , inc. 625 kolter dr. suite # 4 indiana , pa 1-724-465-8762",
    "adverseReactions": "contraindicated persons shown hypersensitivity tetracyclines .",
    "indications_original": "To reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline capsules and other antibacterial drugs, doxycycline capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.\n                  Doxycycline is indicated for the treatment of the following infections:\n                  Rocky Mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox, and tick fevers caused by\n \n  Rickettsiae.\n                  \n                  Respiratory tract infections caused by\n \n  Mycoplasma pneumoniae.\n                  \n                  Lymphogranuloma venereum caused by\n \n  Chlamydia trachomatis.\n                  \n                  Psittacosis (ornithosis) caused by\n \n  Chlamydophila psittaci.\n                  \n                  Trachoma caused by\n \n  Chlamydia trachomatis,although the infectious agent is not always eliminated as judged by immunofluorescence.\n\n \n                  Inclusion conjunctivitis caused by\n \n  Chlamydia trachomatis.\n                  \n                  Uncomplicated urethral, endocervical or rectal infections in adults caused by\n \n  Chlamydia trachomatis.\n                  \n                  Nongonococcal urethritis caused by\n \n  Ureaplasma urealyticum.\n                  \n                  Relapsing fever due to\n \n  Borrelia recurrentis.\n                  \n                  Doxycycline is also indicated for the treatment of infections caused by the following gram-negative microorganisms:\n                  Chancroid caused by\n \n  Haemophilus ducreyi.\n                  \n                  Plague due to\n \n  Yersinia pestis.\n\n \n                  Tularemia due to\n \n  Francisella tularensis.\n\n \n                  Cholera caused by\n \n  Vibrio cholerae.\n\n \n                  Campylobacter fetus infections caused by\n \n  Campylobacter fetus.\n\n \n                  Brucellosis due to\n \n  Brucella species(in conjunction with streptomycin).\n\n \n                  Bartonellosis due to\n \n  Bartonella bacilliformis.\n                  \n                  Granuloma inguinale caused by\n \n  Klebsiella granulomatis.\n                  \n                  Because many strains of the following groups of microorganisms have been shown to be resistant to doxycycline, culture and susceptibility testing are recommended.\n                  Doxycycline is indicated for treatment of infections caused by the following gram-negative microorganisms, when bacteriologic testing indicates appropriate susceptibility to the drug:\n                  \n                     Escherichia coli\n                  \n                  \n                     Enterobacter aerogenes\n                  \n                  \n                     Shigella species\n                  \n                  \n                     Acinetobacter species\n                  \n                  Respiratory tract infections caused by\n \n  Haemophilus influenzae.\n                  \n                  Respiratory tract and urinary tract infections caused by\n \n  Klebsiella species.\n                  \n                  Doxycycline is indicated for treatment of infections caused by the following gram-positive microorganisms when bacteriologic testing indicates appropriate susceptibility to the drug:\n                  Upper respiratory infections caused by\n \n  Streptococcus pneumoniae.\n\n \n                  Anthrax due to\n \n  Bacillus anthracis,including inhalational anthrax (post-exposure): to reduce the incidence or progression of disease following exposure to aerosolized\n \n  Bacillus anthracis.\n                  \n                  When penicillin is contraindicated, doxycycline is an alternative drug in the treatment of the following infections:\n                  Uncomplicated gonorrhea caused by\n \n  Neisseria gonorrhoeae.\n                  \n                  Syphilis caused by\n \n  Treponema pallidum.\n                  \n                  Yaws caused by\n \n  Treponema pallidumsubspecies\n \n  pertenue.\n                  \n                  Listeriosis due to\n \n  Listeria monocytogenes.\n                  \n                  Vincent's infection caused by\n \n  Fusobacterium fusiforme.\n                  \n                  Actinomycosis caused by\n \n  Actinomyces israelii.\n                  \n                  Infections caused by\n \n  Clostridium species.\n                  \n                  In acute intestinal amebiasis, doxycycline may be a useful adjunct to amebicides.\n                  In severe acne, doxycycline may be useful adjunctive therapy.",
    "contraindications_original": "THE USUAL DOSAGE AND FREQUENCY OF ADMINISTRATION OF DOXYCYCLINE DIFFERS FROM THAT OF THE OTHER TETRACYCLINES. EXCEEDING THE RECOMMENDED DOSAGE MAY RESULT IN AN INCREASED INCIDENCE OF SIDE EFFECTS.",
    "warningsAndPrecautions_original": "Doxycycline capsules USP, 100 mg are brown opaque cap and yellow opaque body imprinted with \"LU\" on cap in white ink and \"M73\" on the body in black ink filled with light yellow to grey colored blend.\n                  Each capsule contains doxycycline monohydrate USP equivalent to 100 mg doxycycline.\n                  Doxycycline capsules USP, 100 mg is available in:\n                  \n                  NDC: 70518-0213-00\n                  NDC: 70518-0213-01\n                  NDC: 70518-0213-02\n                  NDC: 70518-0213-03\n                  NDC: 70518-0213-04\n                  NDC: 70518-0213-05\n                  NDC: 70518-0213-06\n                  NDC: 70518-0213-07\n                  NDC: 70518-0213-08\n                  NDC: 70518-0213-09\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  PACKAGING: 20 in 1 BLISTER PACK\n                  PACKAGING: 14 in 1 BOTTLE PLASTIC\n                  PACKAGING: 20 in 1 BOTTLE PLASTIC\n                  PACKAGING: 42 in 1 BOTTLE PLASTIC\n                  PACKAGING: 2 in 1 BOTTLE PLASTIC\n                  PACKAGING: 100 in 1 BOTTLE PLASTIC\n                  PACKAGING: 14 in 1 BLISTER PACK\n                  PACKAGING: 60 in 1 BOTTLE PLASTIC\n                  PACKAGING: 30 in 1 BOTTLE PLASTIC\n                  \n                  Store at 25°C (77°F); excursions permitted to 15 to 30°C (59 to 86°F) [see USP controlled room temperature]. Protect from light.\n                  Dispense in a tight, light-resistant container as defined in the USP/NF.\n                  Dispense in a tight container [see USP].\n                  \n                  \n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions_original": "This drug is contraindicated in persons who have shown hypersensitivity to any of the tetracyclines."
}